NuSirt Biopharma, a company dedicated to improving the lives of those with chronic metabolic diseases, is planning to launch a clinical trial to determine if its patented technology has potential to become a new treatment for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). (Read More)

TVA Medical, Inc., a medical device company developing minimally invasive therapies for patients suffering from End-Stage Renal Disease (ESRD), today announced the completion of a $15 million Series C financing with new investors Baxter Ventures (lead) and Boston Scientific Corporation; existing investors Sante Ventures, S3 Ventures, TriStar Technology Ventures; and other strategic investors. (Read More)

Locally based cardiac data venture InvisionHeart is one of five companies to have been named a finalist in Sink or Swim, a pitch competition that’s part of this week’s Healthcare Supply Chain Association Expo in D.C. Also in the mix are Michigan, North Carolina, Pennsylvania and Illinois. They will go before a panel of judges Tuesday. There’s no money to be won, but the winner will get some advice sessions with group purchasing organization executives. (Read More)